A double blind trial of the effect of cromolyn sodium on exercise-induced bronchospasm

Peyton A. Eggleston; C. Warren Bierman; William E. Pierson; Stanley J. Stamm; Paul P. Van Arsdel

doi:10.1016/0091-6749(72)90079-6

A double blind trial of the effect of cromolyn sodium on exercise-induced bronchospasm

Peyton A. Eggleston, C. Warren Bierman, William E. Pierson, Stanley J. Stamm, Paul P. Van Arsdel

Research output: Contribution to journal › Article › peer-review

Abstract

Nineteen children with atopic airway disease who had a demonstrable post-exercise decrease in forced expiratory volume in one second (FEV₁) using a standardized stress on a cycloergometer were treated with disodium cromoglycate (cromolyn sodium) in a double blind crossover study with a placebo control. Significant reduction of post-exercise bronchospasm was obtained by a single dose of 20 mg. of the drug inhaled one hour before exercise; the effect of the single dose was enhanced if preceded by 3 weeks of daily medication. No side effects were detected during the prolonged use of the drug. The significance of cromolyn's effect on the phenomenon is discussed.

Original language	English (US)
Pages (from-to)	57-63
Number of pages	7
Journal	The Journal of allergy and clinical immunology
Volume	50
Issue number	1
DOIs	https://doi.org/10.1016/0091-6749(72)90079-6
State	Published - Jul 1972
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/0091-6749(72)90079-6

Cite this

@article{ae975609bc5649deaa7d6b0dec2301b7,

title = "A double blind trial of the effect of cromolyn sodium on exercise-induced bronchospasm",

abstract = "Nineteen children with atopic airway disease who had a demonstrable post-exercise decrease in forced expiratory volume in one second (FEV1) using a standardized stress on a cycloergometer were treated with disodium cromoglycate (cromolyn sodium) in a double blind crossover study with a placebo control. Significant reduction of post-exercise bronchospasm was obtained by a single dose of 20 mg. of the drug inhaled one hour before exercise; the effect of the single dose was enhanced if preceded by 3 weeks of daily medication. No side effects were detected during the prolonged use of the drug. The significance of cromolyn's effect on the phenomenon is discussed.",

author = "Eggleston, {Peyton A.} and Bierman, {C. Warren} and Pierson, {William E.} and Stamm, {Stanley J.} and {Van Arsdel}, {Paul P.}",

note = "Funding Information: From the Division of Allergy, ington School of Medicine. Supported in part by Public Health Institutes of Allergy and Infectious Received publication Feb. 3, 1972.",

year = "1972",

month = jul,

doi = "10.1016/0091-6749(72)90079-6",

language = "English (US)",

volume = "50",

pages = "57--63",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - A double blind trial of the effect of cromolyn sodium on exercise-induced bronchospasm

AU - Eggleston, Peyton A.

AU - Bierman, C. Warren

AU - Pierson, William E.

AU - Stamm, Stanley J.

AU - Van Arsdel, Paul P.

N1 - Funding Information: From the Division of Allergy, ington School of Medicine. Supported in part by Public Health Institutes of Allergy and Infectious Received publication Feb. 3, 1972.

PY - 1972/7

Y1 - 1972/7

N2 - Nineteen children with atopic airway disease who had a demonstrable post-exercise decrease in forced expiratory volume in one second (FEV1) using a standardized stress on a cycloergometer were treated with disodium cromoglycate (cromolyn sodium) in a double blind crossover study with a placebo control. Significant reduction of post-exercise bronchospasm was obtained by a single dose of 20 mg. of the drug inhaled one hour before exercise; the effect of the single dose was enhanced if preceded by 3 weeks of daily medication. No side effects were detected during the prolonged use of the drug. The significance of cromolyn's effect on the phenomenon is discussed.

AB - Nineteen children with atopic airway disease who had a demonstrable post-exercise decrease in forced expiratory volume in one second (FEV1) using a standardized stress on a cycloergometer were treated with disodium cromoglycate (cromolyn sodium) in a double blind crossover study with a placebo control. Significant reduction of post-exercise bronchospasm was obtained by a single dose of 20 mg. of the drug inhaled one hour before exercise; the effect of the single dose was enhanced if preceded by 3 weeks of daily medication. No side effects were detected during the prolonged use of the drug. The significance of cromolyn's effect on the phenomenon is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0015364387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015364387&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(72)90079-6

DO - 10.1016/0091-6749(72)90079-6

M3 - Article

C2 - 4624443

AN - SCOPUS:0015364387

VL - 50

SP - 57

EP - 63

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1

ER -

A double blind trial of the effect of cromolyn sodium on exercise-induced bronchospasm

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this